Back

Calcium score for cardiovascular risk profiling and stratification in pan-cancer patients undergoing anti-vegfr-targeted tkis

19 June 2026 (14:15 - 15:15)
Organised by: Logo
Congress Presentation Part of: Immune-mediated cardiovascular toxicity: from early detection to real-world evidence Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Alessandro Cicchetti

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)

9 More presentations in this session

Presentation thumbnail
Clinical significance of early asymptomatic high-sensitivity troponin T elevation in patients receiving immune checkpoint inhibitors
Doctor M. Akagi (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Early subclinical myocardial, vascular and endothelial dysfunction in cancer patients treated with immune checkpoint inhibitors
Doctor E. Karamanolis (Athens, GR)
Abstract Slides
Presentation thumbnail
Glucocorticoid resistant ICI associated myocarditis is defined by an interferon gamma driven myeloid inflammatory signature
Doctor J. Brauer (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Cardiac troponin identifies immune checkpoint inhibitor associated myocarditis and stratifies cardiovascular risk a systematic review and meta analysis
Mr A. Alfehaid (KW)
Abstract Slides
Presentation thumbnail
Cardiac rhythm disorders as cardiovascular toxicity of immune checkpoint inhibitors therapy: incidence and prognostic value
Doctor D. Vlachopoulou (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Immune-mediated cardiovascular toxicity: from early detection to real-world evidence

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer
27 August 2022
thumbnail
Congress Presentation
Cardiovascular and oncologic profiles of patients treated with immune checkpoint inhibitors: Insights from the SIR-CVT Registry
21 June 2025
thumbnail
Congress Presentation
Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events
12 December 2020
thumbnail
Congress Presentation
A novel arterial redox-specific machine learning-derived radiomic signature of perivascular adipose tissue predicts cardiac mortality from routine CCTA
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources